Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Exchange Rate Effect (2019 - 2025)

Addex Therapeutics' Exchange Rate Effect history spans 7 years, with the latest figure at $18.8 billion for Q2 2025.

  • On a quarterly basis, Exchange Rate Effect rose 117.32% to $18.8 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $2.3 billion, a 98.86% decrease, with the full-year FY2025 number at -$42438.8, down 137.3% from a year prior.
  • Exchange Rate Effect came in at $18.8 billion for Q2 2025, up from -$17.3 billion in the prior quarter.
  • The five-year high for Exchange Rate Effect was $170.1 billion in Q4 2023, with the low at -$197.6 billion in Q2 2023.
  • Historically, Exchange Rate Effect has averaged $503.2 million across 5 years, with a median of -$19831.3 in 2023.
  • Biggest five-year swings in Exchange Rate Effect: crashed 255694964.98% in 2023 and later soared 362426319.53% in 2024.
  • Year by year, Exchange Rate Effect stood at -$204783.3 in 2021, then decreased by 14.07% to -$233588.1 in 2022, then soared by 72829467.4% to $170.1 billion in 2023, then crashed by 144.25% to -$75.3 billion in 2024, then surged by 124.94% to $18.8 billion in 2025.
  • Business Quant data shows Exchange Rate Effect for ADXN at $18.8 billion in Q2 2025, -$17.3 billion in Q1 2025, and -$75.3 billion in Q4 2024.